STOCK HOLDERS EQUITY (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 13, 2026 |
Nov. 07, 2025 |
Apr. 02, 2025 |
Nov. 30, 2025 |
Mar. 19, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Dec. 31, 2025 |
Nov. 28, 2025 |
|
| Common stock, shares issued | 2,933,442 | 2,933,442 | 2,417,314 | 175,000 | |||||||
| Common stock, shares outstanding | 2,933,442 | 2,933,442 | 2,417,314 | ||||||||
| Share-based compensation expense | $ 799,998 | $ 0 | $ 799,998 | $ 0 | |||||||
| Description of reverse stock split | effect a reverse stock split of the Company’s outstanding shares of common stock, with a ratio ranging from one-for-five (1:5) to one-for-ten (1:10), with the exact ratio to be set at the discretion of the Board of Directors. Thereafter, on that same date, the Board of Directors set the reverse stock split ratio at 1 for 10 | ||||||||||
| Description of shares issued and outstanding | effect a one for ten (1 for 10) reverse stock split of its issued and outstanding common stock, which became market effective on April 7, 2025. Immediately prior to the reverse stock split, the Company had 17,967,663 shares of common stock issued and outstanding | ||||||||||
| ATM Program [Member] | Form S-3 [Member] | |||||||||||
| Securities rgistered offering amount | $ 100,000,000 | ||||||||||
| Maximum aggregate offering price | $ 20,000,000 | ||||||||||
| Number of shares sold | 53,478 | ||||||||||
| Net proceeds from sales of Stock | $ 267,311 | ||||||||||
| 2025 Equity Incentive Plan [Member] | |||||||||||
| Common stock, shares issued | 516,128 | ||||||||||
| Grant-date fair value | $ 1.55 | ||||||||||
| Share-based compensation expense | $ 799,998 | ||||||||||
| ARC Group Internation Ltd | |||||||||||
| Common stock, shares issued | 175,000 | ||||||||||
| Purchase agreement descreption | from time to time at the Company’s discretion, up to $500,000,000 of the Company’s common stock, no par value per share, over a 36-month period | ||||||||||
| Fidelion Diagnostics Pte. Ltd | |||||||||||
| Common stock, shares issued | 392,329 | ||||||||||